The Osteogenic Priming of Mesenchymal Stem Cells is Impaired in Experimental Diabetes.

about

Insulin-Stimulated Bone Blood Flow and Bone Biomechanical Properties Are Compromised in Obese, Type 2 Diabetic OLETF Rats

P2860

Q57153235-AC56BE4A-14F4-46A1-899F-1FEACCD7E552

P2860

The Osteogenic Priming of Mesenchymal Stem Cells is Impaired in Experimental Diabetes.

Item

http://www.wikidata.org/entity/Q47741794

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

The Osteogenic Priming of Mesenchymal Stem Cells is Impaired in Experimental Diabetes.

@en

The Osteogenic Priming of Mesenchymal Stem Cells is Impaired in Experimental Diabetes.

@nl

type

Item

label

The Osteogenic Priming of Mesenchymal Stem Cells is Impaired in Experimental Diabetes.

@en

The Osteogenic Priming of Mesenchymal Stem Cells is Impaired in Experimental Diabetes.

@nl

prefLabel

The Osteogenic Priming of Mesenchymal Stem Cells is Impaired in Experimental Diabetes.

@en

The Osteogenic Priming of Mesenchymal Stem Cells is Impaired in Experimental Diabetes.

@nl

P1476

The Osteogenic Priming of Mesenchymal Stem Cells is Impaired in Experimental Diabetes.

@en

P2093

J C Silva

http://www.w3.org/2001/XMLSchema#string

P2860

High glucose stimulates adipogenic and inhibits osteogenic differentiation in MG-63 cells through cAMP/protein kinase A/extracellular signal-regulated kinase pathway

Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition

Centrifugal isolation of bone marrow from bone: an improved method for the recovery and quantitation of bone marrow osteoprogenitor cells from rat tibiae and femurae.

Glucose-induced inhibition of in vitro bone mineralization.

Geometric cues for directing the differentiation of mesenchymal stem cells.

Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways

Mechanotransduction across the cell surface and through the cytoskeleton.

Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program.

Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis.

P304

1658-1667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.25126

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Pedro S. Gomes

Maria Helena Fernandes

Paula Sampaio

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25704854

http://www.w3.org/2001/XMLSchema#string

The Osteogenic Priming of Mesenchymal Stem Cells is Impaired in Experimental Diabetes.

about

P2860

P2860

The Osteogenic Priming of Mesenchymal Stem Cells is Impaired in Experimental Diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698